There are also reports on the overexpression and oncogenic functions of DPP3 related to poor survival in numerous other malignancies, including colorectal cancer, where DPP3 was found to target cyclin-dependent kinase 1 (CDK1) [97], multiple myeloma [98], and esophageal carcinoma [99]. The gene discussed is CDK1; the disease is plasma cell myeloma.